Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program results

P. Szaflarski, Jerzy; Martina Bebin, E.; M. Comi, Anne; D. Patel, Anup; Joshi, Charuta; Checketts, Daniel; C. Beal, Jules; C. Laux, Linda; M. De Boer, Lisa; H. Wong, Matthew; Lopez, Merrick; Devinsky, Orrin; D. Lyons, Paul; Pichon Zentil, Pilar; Wechsler, Robert; EAP study group, CBD

doi:10.1111/epi.14477

Public

Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program results

Published in Epilepsia • Jul 12, 2018

Authors:

Jerzy P. Szaflarski

E. Martina Bebin

Anne M. Comi

Abstract

OBJECTIVE: Since 2014, cannabidiol (CBD) has been administered to patients with treatment-resistant epilepsies (TREs) in an ongoing expanded-access program (EAP). We report interim results on the safety and efficacy of CBD in EAP patients treated through December 2016. METHODS: Twenty-five US-based ...

Subject

Medicine

Cannabidiol

Adverse effect

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!